Baby on board: what you need to know about pregnancy in the hemoglobinopathies.
Publication/Presentation Date
1-1-2012
Abstract
Pregnancy poses a unique challenge to patients with sickle cell disease and β-thalassemia, who often have exacerbations of hemolysis or anemia during the gestational period, experience higher rates of obstetric and fetal complications, and may have distinct underlying comorbidities related to vasculopathy and iron overload that can endanger maternal health. Optimal management of pregnant women with hemoglobinopathies requires both an understanding of the physiologic demands of pregnancy and the pathophysiology of disease-specific complications of inherited blood disorders. A multidisciplinary team of expert hematologists and high-risk obstetricians is therefore essential to ensuring appropriate antenatal maternal screening, adequate fetal surveillance, and early recognition of complications. Fortunately, with integrated and targeted care, most women with sickle cell disease and β-thalassemia can achieve successful pregnancy outcomes.
Volume
2012
First Page
208
Last Page
214
ISSN
1520-4383
Published In/Presented At
Naik, R. P., & Lanzkron, S. (2012). Baby on board: what you need to know about pregnancy in the hemoglobinopathies. Hematology. American Society of Hematology. Education Program, 2012, 208–214. https://doi.org/10.1182/asheducation-2012.1.208
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
23233583
Department(s)
Administration and Leadership
Document Type
Article